D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.68% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Orthofix Medical
OFIX
$481M
| $376K | ﹤0.01% |
20,810
-54,506
| -72% | -$1.02M |
|
3402
Eldorado Gold
EGO
$8.48B
| $375K | ﹤0.01% |
+37,120
| New | +$393K |
|
3403
Amcor
AMCR
$20.9B
| $375K | ﹤0.01% |
7,506
-28,314
| -79% | -$1.48M |
|
3404
Home BancShares
HOMB
$6.21B
| $372K | ﹤0.01% |
16,331
-14,621
| -47% | -$319K |
|
3405
Sportsman's Warehouse
SPWH
$44.5M
| $372K | ﹤0.01% |
65,272
-208,076
| -76% | -$1.25M |
|
3406
TransDigm Group
TDG
$71.9B
| $370K | ﹤0.01% |
414
| – | – |
|
|
AEVA
3407
Aeva Technologies
AEVA
$1.06B
| $368K | ﹤0.01% |
58,800
+50,543
| +612% | +$288K |
|
|
HIBB
3408
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $367K | ﹤0.01% |
10,113
-33,721
| -77% | -$1.61M |
|
3409
Anavex Life Sciences
AVXL
$232M
| $367K | ﹤0.01% |
+45,104
| New | +$387K |
|
|
IRRX.WS
3410
DELISTED
Integrated Rail and Resources Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
IRRX.WS
| $367K | ﹤0.01% |
940,000
| – | – |
|
3411
Mizuho Financial
MFG
$129B
| $366K | ﹤0.01% |
119,176
-247,895
| -68% | -$736K |
|
3412
New Mountain Finance
NMFC
$650M
| $365K | ﹤0.01% |
29,315
+7,458
| +34% | +$90K |
|
|
CCRN
3413
DELISTED
Cross Country Healthcare
CCRN
| $362K | ﹤0.01% |
+12,900
| New | +$320K |
|
3414
ALX Oncology
ALXO
$270M
| $362K | ﹤0.01% |
48,207
+7,132
| +17% | +$46.7K |
|
3415
PetMed Express
PETS
$42.3M
| $361K | ﹤0.01% |
+26,185
| New | +$393K |
|
|
IPXXU
3416
DELISTED
Inflection Point Acquisition Corp. II Unit
IPXXU
| $360K | ﹤0.01% |
+35,600
| New | +$360K |
|
3417
Grupo Cibest SA
CIB
$20.9B
| $359K | ﹤0.01% |
+13,453
| New | +$351K |
|
3418
John B. Sanfilippo & Son
JBSS
$980M
| $359K | ﹤0.01% |
3,060
| – | – |
|
3419
Dell
DELL
$276B
| $356K | ﹤0.01% |
6,570
-14,161
| -68% | -$652K |
|
3420
NMI Holdings
NMIH
$3.27B
| $354K | ﹤0.01% |
+13,700
| New | +$332K |
|
3421
Twilio
TWLO
$29.5B
| $352K | ﹤0.01% |
5,537
-235,633
| -98% | -$13.9M |
|
3422
Ovid Therapeutics
OVID
$439M
| $352K | ﹤0.01% |
107,282
-231,878
| -68% | -$787K |
|
3423
Royal Gold
RGLD
$17.1B
| $351K | ﹤0.01% |
3,057
-843
| -22% | -$108K |
|
3424
FerroAtlántica
GSM
$619M
| $351K | ﹤0.01% |
73,543
-313,476
| -81% | -$1.44M |
|
3425
ReNew
RNW
$2.2B
| $350K | ﹤0.01% |
63,954
-47,605
| -43% | -$261K |
|
Similar funds
D.E. Shaw & Co's Q2 2023 Portfolio in Review
As of Q2 2023, D.E. Shaw & Co held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Oracle worth $217M.
- D.E. Shaw & Co's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- D.E. Shaw & Co added most to NVIDIA in Q2 2023, an estimated $997M increase.
- D.E. Shaw & Co's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- D.E. Shaw & Co fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- D.E. Shaw & Co opened 467 new positions and closed 639 in Q2 2023.
- D.E. Shaw & Co's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.